Pregnancy as a Window to the Future (H-53458)

The goal is to determine whether treatment of mild chronic hypertension in pregnancy influences maternal risk of cardiovascular disease (CVD) and to evaluate the long-term effect of superimposed preeclampsia on CVD outcomes in women who had CHTN. The current protocol describes long-term follow up of these women during a 5-year window starting between 0– 6 years until 5 – 10 years after their participation in the original CHAP trial.